Gambro Acquires Memphis Dialysis Clinic.

Business Editors & Health Writers

STOCKHOLM, Sweden--(BUSINESS WIRE)--April 5, 2000

Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that its wholly owned US subsidiary, Gambro Healthcare, Inc., has acquired the assets of the dialysis program at UT Medical Group, Inc. ("UTMG"), located in Memphis, Tennessee.

UTMG's dialysis program consists of incenter hemodialysis, peritoneal dialysis and home training to over 235 patients in the Memphis area. Dr. Sergio Acchiardo has been appointed as the Medical Director of the new Gambro unit.

"Gambro's decision to partner with UT Medical Group is in line with the company's strategic plan to expand dialysis services throughout the state of Tennessee. UT Medical Group, Inc. has a strong reputation for providing quality dialysis treatment to patients in the Memphis area," stated Brad Nutter, President of Gambro Healthcare, Inc.

"This change will allow our physicians to continue providing care to an important group of patients," said UT Medical Group Chief Operating Officer, Richard Baer. "We will be working in close association with a strong national provider of dialysis services and we believe that our combined efforts will make excellent care available to our patients for many years to come."

With this agreement Gambro now provides hemodialysis treatments to over 1,100 patients in twenty outpatient facilities in the state of Tennessee. The Company now owns, operates, manages or provides consulting services to about 480 dialysis centers in the United States that serve about 32,000 patients. There are patients under treatment in centers across 31 states and the District of Columbia.

Gambro Healthcare is a leading provider of kidney dialysis services in the US. Gambro Healthcare is a fully integrated service provider of renal replacement therapy. Its activities include physician practice management, dialysis services, and clinical laboratory services.

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is one of the leading providers of kidney dialysis services in the world. Gambro treats about 44,200 patients in 588 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis concentrates. BCT includes products for the separation and handling of blood components. The group, with revenue of approximately SEK 20 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.